AnnamycinLF liposomal annamycin: Began Phase I safety trial of escalating doses in 25 patients who were treated previously with anthracyclines

Argus Pharmaceuticals Inc. (ARGS), The Woodlands, Texas Product: AnnamycinLF liposomal annamycin, which appears to have lower cardiotoxicity compared to other anthracyclines such as doxorubicin Indic...